Wasatch Advisors’s Kymera Therapeutics KYMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-572,907
Closed -$7.96M 261
2023
Q3
$7.96M Sell
572,907
-626,443
-52% -$12.6M 0.05% 155
2023
Q2
$27.6M Buy
1,199,350
+161,936
+16% +$4.64M 0.17% 107
2023
Q1
$30.7M Buy
1,037,414
+205,193
+25% +$6.62M 0.19% 99
2022
Q4
$20.8M Sell
832,221
-228,340
-22% -$6.09M 0.14% 131
2022
Q3
$23.1M Buy
1,060,561
+489,917
+86% +$12.9M 0.16% 122
2022
Q2
$11.2M Buy
570,644
+333,287
+140% +$7.78M 0.07% 166
2022
Q1
$10M Sell
237,357
-3,594
-1% -$152K 0.05% 185
2021
Q4
$15.3M Sell
240,951
-415
-0.2% -$24.2K 0.06% 177
2021
Q3
$14.2M Buy
241,366
+2,264
+0.9% +$131K 0.06% 191
2021
Q2
$11.6M Buy
+239,102
New +$10.4M 0.05% 201

Other funds holding KYMR